Coverage for Routine Childhood Vaccines Remains Below Prepandemic Levels
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 26, 2025 -- Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood vaccines remained below prepandemic levels, according to a study published online March 26 in Pediatrics.
Malini B. DeSilva, M.D., from HealthPartners Institute in Bloomington, Minnesota, and colleagues examined rotavirus; diphtheria, tetanus, and acellular pertussis; and pneumococcal conjugate vaccine coverage among infants born between Jan. 1, 2018, and May 31, 2023, and assessed factors associated with vaccine uptake. Data were included for 395,143 infants.
The researchers found that at 5 months of age, coverage for two doses of all three vaccines was 87.8 and 80.8 percent in February 2020 and October 2023, respectively. At 12 months, vaccine series completion was highest in January 2020 and lower in October 2023 (92.3 and 89.6 percent, respectively). Having a caregiver whose primary language was not English or Spanish, non-Hispanic Black race, and Medicaid were factors associated with lower vaccine uptake.
"Three years after the start of the COVID-19 pandemic, coverage for selected routine childhood immunizations remained below prepandemic levels," the authors write. "Although our findings highlight population groups for whom focused interventions are needed to improve vaccine coverage, further understanding of how these factors may be related to other sociodemographic and cultural factors, availability of care, structural barriers to accessing care, and vaccine confidence, is needed."
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-27 06:00
Read more

- Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301
- Sarepta Therapeutics Shares Safety Update on Elevidys
- High Levels of Perimenopause-Related Symptoms Seen in Younger Women
- Scent Test Can Sniff Out Cognitive Decline
- NIH Ends Funding for the Effects of Climate Change on Health
- Updates Issued for Optimizing Bowel Preparation Quality for Colonoscopy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions